February 9 2018 marked one-year until the EU Falsified Medicines Directive (FMD) enforcement date, meaning the timeframes are tight for companies who haven’t already started implementation. As a result, many small and mid-sized pharmaceutical companies in particular are looking to outsource their serialization requirements.

In this article with Pharmaceutical Manufacturing, our director of corporate strategy, Dexter Tjoa, discusses what organisations should be looking for when selecting an outsourcing partner and what crucial steps should be taken over the coming months.

Read the full article here: https://www.pharmamanufacturing.com/articles/2018/eu-fmd-the-one-year-countdown